{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T22:19:20Z","timestamp":1771885160647,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007782","name":"Tshwane University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.xphs.2018.06.012","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T13:41:40Z","timestamp":1529588500000},"page":"2720-2730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Drug Quality in South Africa: A Field Test"],"prefix":"10.1016","volume":"107","author":[{"given":"Andreas","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Katerere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Dressman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2018.06.012_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.medmal.2012.04.007","article-title":"Update on counterfeit antibiotics worldwide; public health risks","volume":"42","author":"Delepierre","year":"2012","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.xphs.2018.06.012_bib2","series-title":"Keeping it Real. Combating the spread of fake drugs in poor countries","author":"Harris","year":"2009"},{"key":"10.1016\/j.xphs.2018.06.012_bib3","first-page":"277","article-title":"The antibiotic resistance crisis. Part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P\u00a0T"},{"key":"10.1016\/j.xphs.2018.06.012_bib4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/003335491412900402","article-title":"Antibiotic resistance: a public health crisis","volume":"129","author":"Lushniak","year":"2014","journal-title":"Public Health Rep"},{"key":"10.1016\/j.xphs.2018.06.012_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-3156.1997.d01-403.x","article-title":"Assessment of the incidence of substandard drugs in developing countries","volume":"2","author":"Shakoor","year":"1997","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.xphs.2018.06.012_bib6","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1371\/journal.pmed.1000052","article-title":"Guidelines for field surveys of the quality of medicines: a proposal","volume":"6","author":"Newton","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.xphs.2018.06.012_bib7","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/j.xphs.2017.05.018","article-title":"Poor-quality and counterfeit drugs. A systematic assessment of prevalence and risks based on data published from 2007 to 2016","volume":"106","author":"Koczwara","year":"2017","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.06.012_bib8","unstructured":"Medicines and Related Substances Act 101 of 1965-Schedules. Minister of Health of South Africa; 2015:174."},{"key":"10.1016\/j.xphs.2018.06.012_bib9","series-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2009"},{"key":"10.1016\/j.xphs.2018.06.012_bib10","series-title":"Scheduling of Medicines","first-page":"20","author":"Medicines Control Council","year":"2014"},{"key":"10.1016\/j.xphs.2018.06.012_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2710.2010.01198.x","article-title":"The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India","volume":"36","author":"Seear","year":"2011","journal-title":"J\u00a0Clin Pharm Ther"},{"key":"10.1016\/j.xphs.2018.06.012_bib12","series-title":"WHO: Expert Working Group on SSFFC Definitions Established","author":"Gopakumar","year":"2015"},{"key":"10.1016\/j.xphs.2018.06.012_bib13","series-title":"WHO Member State Mechanism on Substandard\/Spurious\/Falsely-labelled\/Falsified\/Counterfeit (SSFFC) Medical Products","first-page":"4","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.xphs.2018.06.012_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpba.2013.01.009","article-title":"Understanding and fighting the medicine counterfeit market","volume":"87","author":"D\u00e9gardin","year":"2014","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.xphs.2018.06.012_bib15","doi-asserted-by":"crossref","first-page":"e002923","DOI":"10.1136\/bmjopen-2013-002923","article-title":"Substandard and counterfeit medicines: a systematic review of the literature","volume":"3","author":"Almuzaini","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.xphs.2018.06.012_bib16","series-title":"IMPACT International Medical Products Anti-Counterfeiting Taskforce. The Handbook","first-page":"164","year":"2010"},{"key":"10.1016\/j.xphs.2018.06.012_bib17","series-title":"Counterfeit Drugs. Guidelines for the Development of Measures to Combat Counterfeit Drugs","first-page":"62","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.xphs.2018.06.012_bib19","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12936-016-1096-x","article-title":"Fake anti-malarials: start with the facts","volume":"15","author":"Kaur","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.xphs.2018.06.012_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.5588\/ijtld.12.0355","article-title":"Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis","volume":"17","author":"Bate","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.xphs.2018.06.012_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1475-2875-8-22","article-title":"Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria","volume":"8","author":"Onwujekwe","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.xphs.2018.06.012_bib22","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"10.1016\/j.xphs.2018.06.012_bib25","unstructured":"International Pharmaceutical Federation. Tool for Visual Inspection of Medicines. 4. Available at: http:\/\/www.usp.org\/sites\/default\/files\/usp_pdf\/EN\/dqi\/visualInspectionTool.pdf. Accessed January 13, 2015."},{"key":"10.1016\/j.xphs.2018.06.012_bib26","series-title":"USP 40-NF 35 The United States Pharmacopeia and National Formulary 2017. Main edition plus Supplements 1 and 2","year":"2016"},{"key":"10.1016\/j.xphs.2018.06.012_bib27","series-title":"Mechanical Qualification of Dissolution Apparatus 1 and 2","first-page":"10","author":"U.S. Food and Drug Administration","year":"2006"},{"key":"10.1016\/j.xphs.2018.06.012_bib29","unstructured":"Medicines and Related Substances Act 101 of 1965-Regulations Relating to a Transparent Pricing System for Medicines and Scheduled Substances: Dispensing Fee for Pharmacists. 2016:3."},{"key":"10.1016\/j.xphs.2018.06.012_bib31","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1039\/p19840001345","article-title":"Studies on the hydrolysis of clavulanic acid","author":"Finn","year":"1984","journal-title":"J\u00a0Chem Soc, Perkin Trans 1"},{"key":"10.1016\/j.xphs.2018.06.012_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2050-6511-15-13","article-title":"A\u00a0cross-sectional investigation of the quality of selected medicines in Cambodia in 2010","volume":"15","author":"Yoshida","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.xphs.2018.06.012_bib33","first-page":"220","article-title":"Quality of ceftriaxone in Pakistan: reality and resonance","volume":"22","author":"Obaid","year":"2009","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.xphs.2018.06.012_bib34","series-title":"Counterfeit Medicines: An Update on Estimates","first-page":"3","year":"2006"},{"key":"10.1016\/j.xphs.2018.06.012_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/clpt.1994.138","article-title":"Differential absorption of amoxicillin from the human small and large intestine","volume":"56","author":"Barr","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2018.06.012_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/19490976.2016.1267890","article-title":"Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers","volume":"8","author":"Kabbani","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.xphs.2018.06.012_bib37","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pds.1191","article-title":"Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States","volume":"15","author":"Nourjah","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918303459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918303459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:25:47Z","timestamp":1758360347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918303459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0022354918303459"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.06.012","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Quality in South Africa: A Field Test","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}